Arnoud Paul Verhoeff (1960), an epidemiologist, currently works at the Public Health Service of Amsterdam, the Netherlands, within the Department of Healthy Living. He serves as a director of Sarphati Amsterdam, a research institute based in Amsterdam that focuses on the prevention of non-communicable diseases (https://sarphati.amsterdam/). Before that he was a head of the department of Epidemiology, Health Promotion and Care Innovation within the Public Health Service for more than 20 years.
In 1994, he obtained his PhD from the Erasmus University Rotterdam, the Netherlands. Thereafter he spent a year as a visiting scientist at the Harvard School of Public Health in Boston, United States of America. Since 2006, he has also been appointed as a professor of Urban Health and Health Care at the Department of Sociology of the University of Amsterdam, the Netherlands. His research primarily focusses on health disparities, healthcare and demand within urban populations.
Within Sarphati Amsterdam, he is the Principal Investigator of the Amsterdam Infant Microbiome Study (AIMS), a longitudinal cohort study investigating the development of the microbiome in children during their first three years of life (https://aimsonderzoek.nl/). AIMS is one of the cohort studies contributing to MetaHealth.
Arnoud is a member of the Advisory board of MetaHealth.